Premium assistance programs lead to fights between insurers, hospitals

Programs which help customers on the Affordable Care Act (ACA) marketplace buy insurance are being criticized by insurers as they pull out of the exchanges.

Kaiser Health News reports these programs have helped thousands of low-income customers purchase coverage. In one example, 21-year-old Mercedes Nimmer of Madison, Wisconsin, received assistance from UnitedWay of Dane County when federal subsidies left her with a $33 monthly premium—a considerable expense for a multiple sclerosis patient who makes $11,000 per year.

“Oh my gosh, this is a big deal for me to get this help,” Nimmer said, noting the insurance is vital to cover her medications. 

Insurers, however, argue these “steering” programs are unfair, as they drive people to marketplace plans with higher reimbursement for providers when they may qualify for Medicaid or Medicare. CMS has said it may punish dialysis centers that engage in those practices, up to and including changing their Medicaid and Medicare eligibility.

But insurers are already going to the courts to take action against groups paying for marketplace premiums. For more, click on the link below: 

""
John Gregory, Senior Writer

John joined TriMed in 2016, focusing on healthcare policy and regulation. After graduating from Columbia College Chicago, he worked at FM News Chicago and Rivet News Radio, and worked on the state government and politics beat for the Illinois Radio Network. Outside of work, you may find him adding to his never-ending graphic novel collection.

Around the web

Cardiovascular devices are more likely to be in a Class I recall than any other device type. The FDA's approval process appears to be at least partially responsible, though the agency is working to make some serious changes. We spoke to a researcher who has been tracking these data for years to learn more. 

Updated compensation data includes good news for multiple subspecialties. The new report also examines private equity's impact on employment models and how much male cardiologists earn compared to females.

When drugs are on the FDA’s shortage list, outsourcing facilities can produce their own compounded versions. When the FDA removed tirzepatide from that list with no warning, it created a considerable amount of chaos both behind the scenes and in pharmacies all over the country. 

Trimed Popup
Trimed Popup